IKENA Trademark

Trademark Overview

On Tuesday, August 20, 2019, a trademark application was filed for IKENA with the United States Patent and Trademark Office. The USPTO has given the IKENA trademark a serial number of 88585230. The federal status of this trademark filing is REGISTERED as of Tuesday, April 18, 2023. This trademark is owned by Kyn Therapeutics Inc.. The IKENA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Clinical research in the field of cancer therapeutics and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
ikena

General Information

Serial Number88585230
Word MarkIKENA
Filing DateTuesday, August 20, 2019
Status700 - REGISTERED
Status DateTuesday, April 18, 2023
Registration Number7031318
Registration DateTuesday, April 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Clinical research in the field of cancer therapeutics and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 5, 2019
Primary Code042
First Use Anywhere DateTuesday, December 3, 2019
First Use In Commerce DateTuesday, December 3, 2019

Trademark Owner History

Party NameIKENA ONCOLOGY, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIKENA ONCOLOGY, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIkena Oncology, Inc
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameKyn Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02138
Party NameKyn Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02138

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 18, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, February 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, February 17, 2023USE AMENDMENT FILED
Friday, February 17, 2023TEAS STATEMENT OF USE RECEIVED
Friday, August 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2022SOU EXTENSION 5 GRANTED
Tuesday, August 16, 2022SOU EXTENSION 5 FILED
Tuesday, August 16, 2022TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 11, 2022SOU EXTENSION 4 GRANTED
Friday, February 11, 2022SOU EXTENSION 4 FILED
Friday, February 11, 2022TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021SOU EXTENSION 3 GRANTED
Monday, August 16, 2021SOU EXTENSION 3 FILED
Monday, August 16, 2021TEAS EXTENSION RECEIVED
Thursday, February 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 16, 2021SOU EXTENSION 2 GRANTED
Tuesday, February 16, 2021SOU EXTENSION 2 FILED
Tuesday, February 16, 2021TEAS EXTENSION RECEIVED
Wednesday, August 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, August 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020SOU EXTENSION 1 GRANTED
Monday, August 17, 2020SOU EXTENSION 1 FILED
Friday, August 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 17, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 12, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, February 12, 2020ASSIGNED TO LIE
Wednesday, January 29, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2019ASSIGNED TO EXAMINER
Thursday, September 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2019NEW APPLICATION ENTERED

Related Keywords

ikena research pharmaceuticals field clinical providing medical trials information scientific cancer